The National Health and Welfare Commission issued a notice on December 19, requesting further work on the preparation and use of selected drugs in the centralized procurement of drugs organized by the state. The notice requires that we attach great importance to the preparation and rational use of selected drugs, unblock the policy channel for preferential use of selected drugs, improve the level of reasonable use of selected drugs, establish and improve relevant incentive mechanisms and performance evaluation systems, and strengthen the monitoring of the clinical use of selected drugs. Do a good job in policy interpretation and publicity training.

 

The health committees of provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps:

 

Recently, the National Medical Insurance Bureau and other 9 departments issued the "Implementation Opinions on the Expansion of the National Organization of the Centralized Purchase and Use of Drugs to Expand the Regional Scope" (Yibaofa [2019] No. 56), which changed the regional scope of the national organization of centralized procurement and use of drugs from " 4 + 7 "cities expanded to nationwide. In order to implement the requirements of the work, do a good job in the preparation and use of selected drugs, so that the reform results can benefit more people, the relevant requirements are now notified as follows:

 

1. Attach great importance to the selection and rational use of selected drugs

 

Health administration departments and medical institutions at all levels must have a profound understanding of the significance of the national organization of centralized drug procurement and use to promote the linkage of medical, medical insurance, and pharmaceutical reforms, and to provide high-quality and cheap drugs, and attach great importance to the selection and deployment of selected drugs in medical institutions. Use work reasonably. Provincial health and administrative departments should make the central task of centralizing the procurement and use of medicines by the national government as the key task for deployment, scientifically formulate implementation plans, propose specific work requirements, strengthen organizational leadership and overall coordination, and ensure the smooth and smooth implementation of the expansion. .

 

Second, unblock the policy channel that preferentially allocates and uses selected drugs

 

Provincial health administrative departments shall urge and guide medical institutions (including public medical institutions and social medical institutions that voluntarily participate in the expansion of the pilot area) in time to equip and use selected drugs in accordance with the agreed procurement volume reported in the region, to ensure that the contract is completed on time Dosage. The health administrative departments and medical institutions shall not influence the reasonable use and supply guarantee of the selected drugs on the grounds of cost control, proportion of medicines, requirements on the quantity and quantity of medicines used in medical institutions, and examination and approval by the Pharmaceutical Affairs Commission. Medical institutions should be guided by clinical needs, further optimize the drug structure, and include the selected drugs into their drug prescription sets and basic drug supply catalogs. The medical consortium is encouraged to implement a unified catalogue of selected drug supplies, and implement unified procurement and distribution of selected drugs.

 

3. Raise the level of rational use of selected drugs

 

Medical institutions should strengthen the rational use management of selected drugs, standardize the behavior of clinical drugs by formulating and improving drug use guidelines, including the selected drugs into the clinical path, and strengthening medical staff training. Physicians should make reasonable prescriptions based on diagnosis and treatment specifications, drug instructions, medication guidelines, etc., and preferentially use selected drugs under the premise of ensuring medical quality and safety. Medical institutions should strengthen prescription review and prescription reviews, and medical personnel who do not use selected drugs according to regulations shall be dealt with seriously in accordance with the corresponding provisions of the "Administrative Measures on Prescriptions" and "Management Specifications for Hospital Prescription Reviews (Trial)". Encourage the provision of pharmaceutical services such as pharmacy clinics, drug reformation, and medication monitoring for key patients using selected drugs. Areas with conditions can improve the convenience of pharmacy services through informatization.

 

Fourth, establish and improve the relevant incentive mechanism and performance evaluation system

 

The main person in charge of the medical institution is the first person responsible for the selection and use of medicines. Provincial health and health administrative departments and public medical institutions shall incorporate the use of selected drugs into the performance assessment and performance allocation of public medical institutions and their medical personnel. For medical institutions, clinical departments and physicians that preferential and reasonable use and guaranteed dosage, they should be slanted in public hospital reform awards, priority evaluations, and job title evaluations; for those that cannot be equipped or purchased in insufficient quantities, or clinically unreasonable In public hospitals with serious problems such as use, measures such as unqualified assessments and notifications within a certain range shall be given in the assessment of medical institutions and the assessment of the target responsibilities of persons in charge of medical institutions to promote the formation of guidance to encourage the use of selected drugs. Based on the performance appraisal of the third-level public hospitals, the index of "the proportion of selected drugs used in the centralized procurement of drugs organized by the state" was gradually extended to the second-level public hospitals. It is necessary to fully mobilize the enthusiasm of medical personnel, and the balance of revenue and expenditure of medical services, in accordance with the requirements of the "two allow", as a whole, for medical personnel salaries and expenditures.

 

5. Strengthen the monitoring of the clinical use of selected drugs

 

Health administrative departments and medical institutions should use informational methods to establish and improve the monitoring and evaluation and early warning system for the use of selected drugs. Relying on information platforms such as drug procurement and use, establish unobstructed, timely and efficient information reporting and feedback channels, timely statistics on the use of selected drugs, and monitor and analyze the safety, effectiveness, rationality and economy of clinical use of selected drugs And evaluation, and regularly report the monitoring results and related information. For the use of selected drugs may lead to the adjustment of the patient's medication, medical institutions should do a good job of clinical risk assessment, plan development, do a good job of drug monitoring and emergency treatment, and explain the patient. Early warnings should be given to possible shortages or quality problems of medicines, and they should be reported to the health administrative department in time.

 

Sixth, do a good job of policy interpretation and publicity training

 

The health administrative departments at all levels should improve their political positions, widely carry out publicity and training of medical personnel, so that they can deeply understand the significance of the national organization of centralized procurement of drugs, preferential use of selected drugs in the diagnosis and treatment process, and rationally guide patients' medication habits Good communication. All localities should strengthen policy interpretation and positive publicity, strive for the understanding and support of the public, especially the key patient groups, improve patients' understanding of consistency evaluation and confidence in generic drugs, and create a good atmosphere of public opinion.

 

If you encounter problems in the process of work, please contact our committee in time. Our committee will organize investigations and inspections in due course to ensure the smooth progress of the expansion of the pilot area.

 

Reprint please indicate the source: HC3i Digital Medical Network